FDA Approved: OMLONTI — Original Application (Ocuvex Therapeutics, Inc.)

View source ↗

Summary

The FDA approved OMLONTI (omidenepag isopropyl) from Ocuvex Therapeutics as an Original Application (NDA 215092) for reducing intraocular pressure in adults wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• OMLONTI (omidenepag isopropyl)

Snippet

ORIG AP for OMLONTI (OMIDENEPAG ISOPROPYL)